AdministrationAgreement-v1.1(2021EN)
General information
Name: nl.zorg.AdministrationAgreement 
Version: 1.1
HCIM Status:Final
Release: 2021
Release status: Prepublished
Release date: 01-12-2021
Metadata
| DCM::CoderList | Projectgroep Medicatieproces |
| DCM::ContactInformation.Address | |
| DCM::ContactInformation.Name | * |
| DCM::ContactInformation.Telecom | |
| DCM::ContentAuthorList | Projectgroep Medicatieproces |
| DCM::CreationDate | 1-2-2017 |
| DCM::DeprecatedDate | |
| DCM::DescriptionLanguage | nl |
| DCM::EndorsingAuthority.Address | |
| DCM::EndorsingAuthority.Name | PM |
| DCM::EndorsingAuthority.Telecom | |
| DCM::Id | 2.16.840.1.113883.2.4.3.11.60.40.3.9.8 |
| DCM::KeywordList | Medicatie, Toediening |
| DCM::LifecycleStatus | Final |
| DCM::ModelerList | Architectuurgroep Registratie aan de Bron |
| DCM::Name | nl.zorg.Toedieningsafspraak |
| DCM::PublicationDate | 01-12-2021 |
| DCM::PublicationStatus | Prepublished |
| DCM::ReviewerList | Projectgroep Medicatieproces & Architectuurgroep Registratie aan de Bron |
| DCM::RevisionDate | 28-07-2021 |
| DCM::Supersedes | nl.zorg.Toedieningsafspraak-v1.0.3 |
| DCM::Version | 1.1 |
| HCIM::PublicationLanguage | EN |
Revision History
Only available in Dutch
Publicatieversie 1.0 (04-09-2017)
Publicatieversie 1.0.1 (31-12-2017)
| ZIB-643 | Kleine tekstuele verbeteringen |
Publicatieversie 1.0.2 (31-01-2020)
| ZIB-888 | terminologie reden voor stoppen medicatie verbeteren en SNOMED coderingen zibs met meditatieproces gelijktrekken |
Publicatieversie 1.0.3 (01-09-2020)
| ZIB-911 | Correction English "Farmaceutical" |
| ZIB-1006 | Typo Toedieningsafspraak stop type: een 'g' teveel |
Publicatieversie 1.1 (01-12-2021)
| ZIB-1261 | Medicatieafspraak waardelijst MedicatieafspraakStopTypeCodelijst bevat vervallen SNOMED CT codes |
| ZIB-1454 | Onduidelijkheid codes bij StopType codelijsten |
| ZIB-1457 | Verwijderen woord 'voorlopig' |
| ZIB-1468 | AdministrationAgreement.supplier verkeerde vertaling |
Concept
An administration agreement is the use (or administering) instructions from the pharmacist to the patient (or their representative or administrator), whereby a medication agreement is structured at a concrete level.
Purpose
The goal of the administration agreement is to provide insight into the concrete instructions for administration/use of medication.
Information Model
| Type | Id | Concept | Card. | Definition | DefinitionCode | Reference | |||||||
|
NL-CM:9.8.20132 |  AdministrationAgreement
|
Root concept of the AdministrationAgreement information model. This root concept contains all data elements of the AdministrationAgreement information model. |
|
|||||||||
|
NL-CM:9.8.22097 |  Supplier::HealthcareProvider
|
0..1 | The supplier (pharmacist) that entered the administration agreement. |
| ||||||||
|
|
NL-CM:9.8.20237 | MedicineForAdministrationAgreement::PharmaceuticalProduct
|
1 | Medicine in the AdministrationAgreement. |
| ||||||||
|
|
NL-CM:9.8.22098 | InstructionsForUse
|
0..1 | Instructions for administering the medication, e.g. dose and route of administration. |
| ||||||||
|
NL-CM:9.8.20133 | AdministrationAgreementDateTime
|
0..1 | The time at which the agreement was made. | |||||||||
|
NL-CM:9.8.22499 | AgreementReason
|
0..1 | Reason for this agreement. This will often be the same reason as the one for the medication agreement.
This field has the option to - if applicable - enter a specific reason for the administration agreement. Examples include: substitution, transfer to GDS, patient request for different product, etc. |
|
||||||||
|
|
NL-CM:9.8.22660 | PeriodOfUse
|
1 | Start date: This is the time at which the agreement was to take effect (or took effect or will take effect). This is the time at which the instructions for use in this agreement start. In the case of an agreement to discontinue use, this is the start date of the original administration agreement. The end date indicates from when the medication is to be discontinued.
Duration: The intended duration of use. E.g. 5 days or 8 weeks. It is not allowed to indicate the duration in months, because different months have a variable duration in days.
End date: The time at which the period of use ends (or ended or will end). In the case of an agreement to discontinue use, this is the time at which the medication is to be discontinued. To avoid confusion between 'to' and 'up to', the submission of time is always mandatory for the end date. |
| ||||||||
|
|
NL-CM:9.8.22394 | MedicationAgreement
|
0..1 | Relationship to the medication agreement on which the administration agreement is based. |
| ||||||||
|
NL-CM:9.8.22498 | AdministrationAgreementStopType
|
0..1 | Stop type, the manner in which this medication is discontinued (temporary or definitive). |
| ||||||||
|
NL-CM:9.8.23034 | CanceledIndicator
|
0..1 | In the event of an error correction, this indicator is to be put on for the incorrect agreement. | |||||||||
|
|
NL-CM:9.8.23284 | AdministrationAgreementAdditionalInformation
|
0..* | Additional information includes details on the structure of the agreement made.
This element mainly contains information that until now has been structured with ZZ rules. The medication-related topics that are now supported by the ZZ rules are best supported with a system functionality. A process has been started for this by Z-index/KNMP. For now, the following list will be used. This list will be replaced by a thesaurus in the G standard at a later stage. |
| ||||||||
|
|
NL-CM:9.8.22275 | Comment
|
0..1 | Comments on the administration agreement. |
|
||||||||
Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page 
Example Instances
Only available in Dutch
| ToedieningsAfspraakDatumTijd | Gebruiksperiode | GeneesmiddelBijToedieningsafspraak | Verstrekker | GeannuleerdIndicator | ToedieningsafspraakStoptype | ||
| Ingangsdatum | Einddatum | Duur | ProductCode | Zorgaanbieder | |||
| 2-5-2012 12:14:09 | 02-05-12 | 4 weken | Paracetamol tablet 500 mg | Apotheek De Gulle Gaper | |||
| 10-9-2015 9:16:31 | 5 dagen | Pantoprazol injpdr 40 mg fl | Apotheek De Gulle Gaper | Ja | |||
| 19-9-2014 7:12:59 | 19-09-14 | 18-12-14 | Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml | Poli-apotheek Het Ziekenhuis | |||
| 30-8-2013 8:41:43 | 01-08-13 | 30-08-13 | Prednison 5 mg | Poli-apotheek Het Ziekenhuis | Definitief |
| Gebruiksinstructie | ||||||
| Omschrijving | ToedieningsWeg | HerhaalperiodeCyclischSchema | Doseerinstructie | |||
| Doseerduur | Dosering|Keerdosis | Toedieningsschema|Frequentie|Interval|Toedientijd|Weekdag|Dagdeel | Zo nodig | |||
| Vanaf 2 mei gedurende 4 weken zo nodig bij pijn 500 mg (=1 st), max. 4x per dag | oraal | 1 | 4 weken | 1 stuk | max. 4x/dag | Bij pijn |
| Gedurende 5 dagen 1x/dag (8u) 40 mg (=1 st) | iv | 40 mg (=1 st) | 1x per dag om 8.00 uur | |||
| Vanaf 19-9-2014 tot 18-12-2014 1x per dag om 18uur 2500ie(=0,2ml) | subcutaan | 2500 IE (=0,2 ml) | 1x per dag om 18.00 uur | |||
| Van 1-8-2013 tot 30-8-2013 volgens afbouwschema. Per 30-8-2013 onderbreken. | oraal | 1 |
Valuesets
AdministrationAgreementAdditionalInformationCodeList
| Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.8.2 | Binding: Required |
| Conceptname | Conceptcode | Codesystem name | Codesystem OID | Description |
| Geneesmiddel niet verstrekt | 1 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Geneesmiddel niet verstrekt |
| Niet leverbaar | 2 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Niet leverbaar |
| Medicatieafspraak gewijzigd: substantie | 3 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Medicatieafspraak gewijzigd: substantie |
| Medicatieafspraak gewijzigd: dosering | 4 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Medicatieafspraak gewijzigd: dosering |
| Medicatieafspraak gewijzigd: farmaceutische vorm | 5 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Medicatieafspraak gewijzigd: farmaceutische vorm |
| Medicatieafspraak gewijzigd: verwisseling van persoon | 6 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Medicatieafspraak gewijzigd: verwisseling van persoon |
| Machtiging aangevraagd | 7 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Machtiging aangevraagd |
| Machtiging afgewezen | 8 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Machtiging afgewezen |
| Machtiging in gebruik nemen | 9 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Machtiging in gebruik nemen |
| Gebruiksinstructie gegeven | 10 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Gebruiksinstructie gegeven |
| Controle inhalatietechniek | 11 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Controle inhalatietechniek |
| Meter periodieke controle | 12 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Meter periodieke controle |
| Pen controle/omruil | 13 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Pen controle/omruil |
| Bijwerking besproken | 14 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Bijwerking besproken |
| Afhandeling bijwerking niet-lareb | 15 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Afhandeling bijwerking niet-lareb |
| Melding lareb | 16 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Melding lareb |
| Medicatiebewaking OT | 17 | Aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | Medicatiebewaking OT |
AdministrationAgreementStopTypeCodeList
| Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.8.1 | Binding: Required |
| Conceptname | Conceptcode | Codesystem name | Codesystem OID | Description |
| Drug therapy temporarily stopped | 113381000146106 | SNOMED CT | 2.16.840.1.113883.6.96 | Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie). |
| Drug therapy definitely stopped | 113371000146109 | SNOMED CT | 2.16.840.1.113883.6.96 | Het staken van een bestaande medicamenteuze behandeling. |
This information model in other releases
- Release 2017, (Version 1.0.1)
- Prerelease 2018-2, (Version 1.0.1)
- Prerelease 2019-2, (Version 1.0.2)
- Release 2020, (Version 1.0.3)
- Prerelease 2022-1, (Version 2.0)
- Prerelease 2023-1, (Version 2.1)
- Prerelease 2024-1, (Version 3.0)
Information model references
This information model refers to
- HealthcareProvider-v3.4
- InstructionsForUse-v1.3
- MedicationAgreement-v1.3
- PharmaceuticalProduct-v2.1.3
- TimeInterval-v1.1
This information model is used in
Technical specifications in HL7v3 CDA and HL7 FHIR
To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
- HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment
- HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR
Downloads
This information model is also available as pdf file 
or as spreadsheet 
About this information
The information in this wikipage is based on Pre-release 2021-2
SNOMED CT and LOINC codes are based on:
- SNOMED Clinical Terms version: 20210731 [R] (July 2021 Release)
- LOINC version 2.67
Conditions for use are located on the mainpage
This page is generated on 30/11/2021 09:46:33 with ZibExtraction v. 6.4.8004.1652